Enanta Pharmaceuticals Inc (ENTA)
12.81
+0.34
(+2.73%)
USD |
NASDAQ |
May 22, 16:00
12.80
-0.01
(-0.08%)
After-Hours: 20:00
Enanta Pharmaceuticals Free Cash Flow: -113.29M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -113.29M |
| December 31, 2023 | -99.19M |
| September 30, 2023 | -112.21M |
| June 30, 2023 | -106.21M |
| March 31, 2023 | -101.79M |
| December 31, 2022 | -112.07M |
| September 30, 2022 | -86.91M |
| June 30, 2022 | -90.99M |
| March 31, 2022 | -91.04M |
| December 31, 2021 | -69.30M |
| September 30, 2021 | -70.75M |
| June 30, 2021 | -65.48M |
| March 31, 2021 | -40.34M |
| December 31, 2020 | -21.31M |
| September 30, 2020 | 5.643M |
| June 30, 2020 | 29.68M |
| March 31, 2020 | 34.75M |
| December 31, 2019 | 48.01M |
| September 30, 2019 | 66.00M |
| June 30, 2019 | 85.47M |
| March 31, 2019 | 88.11M |
| December 31, 2018 | 52.20M |
| September 30, 2018 | 26.24M |
| June 30, 2018 | 55.59M |
| Date | Value |
|---|---|
| March 31, 2018 | 47.11M |
| December 31, 2017 | 51.86M |
| September 30, 2017 | 50.15M |
| June 30, 2017 | -9.466M |
| March 31, 2017 | -6.654M |
| December 31, 2016 | 5.467M |
| September 30, 2016 | 31.07M |
| June 30, 2016 | 29.66M |
| March 31, 2016 | 17.78M |
| December 31, 2015 | 108.00M |
| September 30, 2015 | 74.34M |
| June 30, 2015 | 72.88M |
| March 31, 2015 | 122.21M |
| December 31, 2014 | 19.18M |
| September 30, 2014 | 19.15M |
| June 30, 2014 | 21.86M |
| March 31, 2014 | -18.84M |
| December 31, 2013 | -4.882M |
| September 30, 2013 | 10.05M |
| June 30, 2013 | 10.94M |
| March 31, 2013 | 13.04M |
| December 31, 2012 | 34.62M |
| September 30, 2012 | 22.37M |
Free Cash Flow Range, Past 5 Years
-113.29M
Minimum
Mar 2024
85.47M
Maximum
Jun 2019
-45.57M
Average
-70.02M
Median
Free Cash Flow Benchmarks
| Madrigal Pharmaceuticals Inc | -391.12M |
| Galectin Therapeutics Inc | -34.28M |
| Viking Therapeutics Inc | -54.87M |
| Akero Therapeutics Inc | -155.88M |
| 89bio Inc | -138.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -28.60M |
| Cash from Investing (Quarterly) | 58.62M |
| Cash from Financing (Quarterly) | -6.414M |
| Free Cash Flow Per Share (Quarterly) | -1.43 |
| Free Cash Flow to Equity (Quarterly) | -30.27M |
| Free Cash Flow to Firm (Quarterly) | -30.27M |
| Free Cash Flow Yield | -41.96% |